|
Drugmakers Press Broader Expansion of Health Canada’s SBD Initiative
Drug and medical device companies and some local government officials are urging Health Canada to expand its summary basis of decision (SBD) initiative so product approval reports are published more quickly and on a wider range of products.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives